Literature DB >> 1858677

Outcome of infants and children with dilated cardiomyopathy.

A B Lewis1, M Chabot.   

Abstract

A review of 81 infants and children with dilated, poorly contracting left ventricles without associated structural abnormalities was undertaken to identify risk factors for poor outcome, which could be used in selecting candidates for cardiac transplantation. Significant atrial or ventricular dysrhythmias, or both, were detected on presentation or during follow-up in 24 patients. Arrhythmias were present in only 8 of 51 survivors (16%) but were detected in 16 of 30 patients (53%) who died (p less than 0.05). Patients dying suddenly were even more likely to have had documented dysrhythmias (8 of 11, p less than 0.05). Left ventricular shortening fraction was similar in survivors and nonsurvivors (14.9 +/- 1.0% vs 15.3 +/- 1.7%). Left ventricular end-diastolic pressure in 44 patients who had cardiac catheterization averaged 20.8 +/- 1.6 mm Hg. Left ventricular end-diastolic pressure was significantly higher in patients who died than in those who survived (29.5 +/- 2.2 vs 15.0 +/- 1.6 mm Hg, p less than 0.001). Analysis of actuarial survival revealed that mortality was highest during the first 6 months after presentation (19% mortality). Survival declined more gradually thereafter and was 70% at 2 years, 64% at 5 years and 52% after 11.5 years. Age at initial presentation did not have any significant impact on survival. However, left ventricular end-diastolic pressure greater than 25 torr was associated with a significantly increased mortality rate (p less than 0.05). Early cardiac transplantation should be considered in patients with markedly elevated left ventricular end-diastolic pressure or complex atrial or ventricular arrhythmias.

Entities:  

Mesh:

Year:  1991        PMID: 1858677     DOI: 10.1016/0002-9149(91)90833-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.

Authors:  J Soongswang; C Sangtawesin; K Durongpisitkul; D Laohaprasitiporn; A Nana; K Punlee; C Kangkagate
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report.

Authors:  E Kitzmüller; A Gruber; M Marx; M Schlemmer; M Wimmer; B Richling
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  Presentation, management and outcomes of thrombosis for children with cardiomyopathy.

Authors:  Brian W McCrindle; Tara Karamlou; Harvey Wong; Nirupama Gangam; Kalyani R Trivedi; Kyong-Jin Lee; Lee N Benson
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

Review 4.  A practical approach for the diagnosis and management of dilated cardiomyopathy.

Authors:  R Krishna Kumar
Journal:  Indian J Pediatr       Date:  2002-04       Impact factor: 1.967

5.  Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.

Authors:  G Müller; H E Ulmer; K J Hagel; D Wolf
Journal:  Pediatr Cardiol       Date:  1995 Mar-Apr       Impact factor: 1.655

6.  Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review.

Authors:  Jorge A Alvarez; James D Wilkinson; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2007-09-01

7.  Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry).

Authors:  William G Harmon; Lynn A Sleeper; Leigha Cuniberti; Jane Messere; Steven D Colan; E John Orav; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  Am J Cardiol       Date:  2009-06-03       Impact factor: 2.778

8.  Dilated cardiomyopathy in children: determinants of outcome.

Authors:  M Burch; S A Siddiqi; D S Celermajer; C Scott; C Bull; J E Deanfield
Journal:  Br Heart J       Date:  1994-09

9.  QT intervals in metabolic dilated cardiomyopathy.

Authors:  Lindsay M Ryerson; R Michael Giuffre
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

10.  Severe reversible cardiomyopathy in four unrelated infants associated with mitochondrial DNA D-loop heteroplasmy.

Authors:  R G Boles; C Luna; M Ito
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.